CHINO HILLS, CALIFORNIA / ACCESS Newswire / November 4, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

Dr. Katz's research shows how important it is for all breast cancer survivors to have access to genetic testing services, ...

Researchers have gained new insights into the genetic basis of rye reproduction. They have demonstrated how plants recombine ...

Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

How they’re doing it: The new company, called Preventive, is being formed to research so-called “heritable genome editing,” ...

A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

The stakes could scarcely be higher. Scientists make key breakthrough in effort to protect food supply: 'We can better ...

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Dive into the thrilling world of genetic engineering and creativity in our latest video, "How to Make a Zombie Megalodon ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Advances in cancer immunotherapy from immune checkpoint modulation to adoptive cell transfer of tumour-infiltrating ...